While GLP-1R agonists have been demonstrated to attenuate hypertension in response to high-salt load and angiotensin-II infusion in rodents [37,38], human studies suggest that GLP-1 receptor agonists can reduce circulating angiotensin-II levels in the absence of blood pressure effects [39,40,41]. This evidence concerns the gene GLP1R and hypertensive disorder.